Prevalence of chronic pain with neuropathic characteristics in the general population, Pain, vol.136, issue.3, pp.380-387, 2008. ,
DOI : 10.1016/j.pain.2007.08.013
URL : https://hal.archives-ouvertes.fr/inserm-00326893
Prevalence of neuropathic pain in emergency patients: an observational study, The American Journal of Emergency Medicine, vol.29, issue.1, pp.43-49, 2011. ,
DOI : 10.1016/j.ajem.2009.07.009
classification of chronic pain. Descriptions of chronic pain syndromes and definition of terms, 1994. ,
Mécanismes physiopathologiques, Rueil Malmaison, vol.4, pp.49-50, 2007. ,
EFNS guidelines on neuropathic pain assessment, European Journal of Neurology, vol.12, issue.3, pp.153-62, 2004. ,
DOI : 10.1016/0304-3959(94)00132-X
Chapter 34 Classification of neuropathic pain syndromes based on symptoms and signs, Handbook of clinical neurology, vol.81, pp.517-546, 2006. ,
DOI : 10.1016/S0072-9752(06)80038-2
Translation of symptoms and signs into mechanisms in neuropathic pain, Pain, vol.102, issue.1, pp.1-8, 2003. ,
DOI : 10.1016/s0304-3959(03)00006-x
Neuropathic pain, The Lancet, vol.354, issue.9182, pp.1959-64, 1999. ,
DOI : 10.1016/S0140-6736(05)75705-6
Définitions, classification et diagnostic. Douleurs neuropathiques. Arnette, Ed Rueil Malmaison, vol.1, p.6, 2007. ,
Vanilloid Receptor Antagonists: Emerging Class of Novel Anti-Inflammatory Agents for Pain Management, Current Pharmaceutical Design, vol.15, issue.9, pp.1008-1034, 2009. ,
DOI : 10.2174/138161209787581995
What is localised neuropathic pain? A first proposal to characterise and define a widely used term (Qu'est-ce que la douleur neuropathique localisée ? ,
Prise en charge diagnostique des neuropathies périphériques, Mai, vol.8, 2007. ,
EFNS guidelines on neuropathic pain assessment, European Journal of Neurology, vol.12, issue.3, pp.1010-1018, 2009. ,
DOI : 10.1016/0304-3959(94)00132-X
The Neuropathic Components of Chronic Low Back Pain: A Prospective Multicenter Study Using the DN4 Questionnaire, The Journal of Pain, vol.12, issue.10, pp.1080-1087, 2011. ,
DOI : 10.1016/j.jpain.2011.05.006
Etiologies et aspects cliniques ,
Epidemiology and Impact on Quality of Life of Postherpetic Neuralgia and Painful Diabetic Neuropathy, The Clinical Journal of Pain, vol.18, issue.6, pp.350-354, 2002. ,
DOI : 10.1097/00002508-200211000-00002
The burden of neuropathic pain : results from a cross-sectional survey, Eur J Pain, 2006. ,
A cross-sectional survey of health state impairment and treatment patterns in patients with postherpetic neuralgia, Age and Ageing, vol.35, issue.2, pp.132-169, 2006. ,
DOI : 10.1093/ageing/afj048
Pain, Medication Use, and Health-Related Quality of Life in Older Persons With Postherpetic Neuralgia: Results From a Population-Based Survey, The Journal of Pain, vol.6, issue.6, pp.356-63, 2005. ,
DOI : 10.1016/j.jpain.2005.01.359
Advances in Neuropathic Pain, Archives of Neurology, vol.60, issue.11, pp.1524-1558, 2003. ,
DOI : 10.1001/archneur.60.11.1524
Algorithm for neuropathic pain treatment: An evidence based proposal, Pain, vol.118, issue.3, pp.289-305, 2005. ,
DOI : 10.1016/j.pain.2005.08.013
Neuropathicpain : a pratical guide for the clinicien, CMAJ, vol.176, pp.265-75, 2006. ,
Anticonvulsants in neuropathic pain: rationale and clinical evidence, European Journal of Pain, vol.73, issue.Suppl 6 ,
DOI : 10.1053/eujp.2001.0324
Antidepressants in the Treatment of Neuropathic Pain, Basic <html_ent glyph="@amp;" ascii="&"/> Clinical Pharmacology <html_ent glyph="@amp;" ascii="&"/> Toxicology, vol.58, issue.6, pp.399-409, 2005. ,
DOI : 10.1016/S0140-6736(99)01307-0
Clinical trial outcome in neuropathic pain: Relationship to study characteristics, Neurology, vol.70, issue.4, pp.263-72, 2008. ,
DOI : 10.1212/01.wnl.0000275528.01263.6c
Morphine, Gabapentin, or Their Combination for Neuropathic Pain, New England Journal of Medicine, vol.352, issue.13, pp.1324-1358, 2005. ,
DOI : 10.1056/NEJMoa042580
Nortritpyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomised controlled crossover trial, Lancet, 2009. ,
expertise en gestion de la douleur chronique (CEGDC) associé au réseau universitaire intégré en santé (RUIS) de l'Université de Montréal sous la direction de Dr Aline Boulanger Algorithme de prise en charge de la douleur neuropathique. La Direction des communications du ministère de la Santé et des Services sociaux Disponible sur http, Mars, vol.7, pp.14-947, 2014. ,
Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain, Annals of Neurology, vol.156, issue.suppl 173, pp.274-84, 2008. ,
DOI : 10.1002/ana.21427
URL : https://hal.archives-ouvertes.fr/inserm-00292356
Les douleurs neuropathiques chroniques??: diagnostic, ??valuation et traitement en m??decine ambulatoire. Recommandations pour la pratique clinique de la Soci??t?? fran??aise d?????tude et de traitement de la douleur, Douleurs : Evaluation - Diagnostic - Traitement, vol.11, issue.1, 2010. ,
DOI : 10.1016/j.douler.2009.12.009
Temporary Abolition of Pain in Man, Science, vol.155, issue.3758, pp.108-117, 1967. ,
DOI : 10.1126/science.155.3758.108
Effects of TENS frequency, intensity and stimulation site parameter manipulation on pressure pain thresholds in healthy human subjects, Pain, vol.106, issue.1, pp.73-80, 2003. ,
DOI : 10.1016/S0304-3959(03)00292-6
Hypnosis for chronic pain management: A new hope, Pain, vol.146, issue.3, pp.235-237, 2009. ,
DOI : 10.1016/j.pain.2009.06.027
Traitements non m??dicamenteux de la douleur neuropathique, La Presse M??dicale, vol.37, issue.2, pp.354-357, 2008. ,
DOI : 10.1016/j.lpm.2007.11.008
Psychological approaches in the treatment of chronic pain patients -When pills, scalpels, and needles are not enough, Canadian Journal of Psychiatry, vol.53, pp.213-236, 2008. ,
NGX- 4010 C119 Study Group. A randomized, double-blind, controlled study of NGX-4010, a capsaicin 8% dermal patch, for the treatment of painful HIV-associated distal sensory polyneuropathy, Journal of Acquired Immune Deficiency Syndromes, vol.589, issue.2, pp.126-159, 2012. ,
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study, The Lancet Neurology, vol.7, issue.12, pp.1106-1118, 2008. ,
DOI : 10.1016/S1474-4422(08)70228-X
A Multicenter, Randomized, Double-Blind, Controlled Study of NGX-4010, a High-Concentration Capsaicin Patch, for the Treatment of Postherpetic Neuralgia, Pain Medicine, vol.12, issue.1, pp.99-109, 2011. ,
DOI : 10.1111/j.1526-4637.2010.01004.x
NGX-4010, a high-concentration capsaicin patch, for the treatment of postherpetic neuralgia: a randomised, double-blind study, The Lancet Neurology, vol.7, issue.12, pp.1106-1118, 2008. ,
DOI : 10.1016/S1474-4422(08)70228-X
Controlled trial of high-concentration capsaicin patch for treatment of painful HIV neuropathy, Neurology, vol.70, issue.24, pp.2305-2318, 2008. ,
DOI : 10.1212/01.wnl.0000314647.35825.9c
Long-Term Safety of NGX-4010, a High-Concentration Capsaicin Patch, in Patients with Peripheral Neuropathic Pain, Journal of Pain and Symptom Management, vol.39, issue.6, pp.1053-64, 2010. ,
DOI : 10.1016/j.jpainsymman.2009.11.316
Matin/12-12h20-dr-robard-bordeaux-sfco- 2015-prise-en-charge-des-douleurs-neuropathiques-en-cancerologie.pdf 62. agence française de sécurité sanitaire des produits de santé, 2011. ,